METROPOLIS.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	100 470
Gjennomsnittsvolum	388 837
Markedsverdi	91.90B
EPS	INR0 ( 2024-02-04 )
Neste inntjeningsdato	( INR13.40 ) 2024-05-13
Last Dividend	INR8.00 ( 2023-02-23 )
Next Dividend	INR0 ( N/A )
P/E	73.62
ATR14	INR1.814 (0.10%)

Volum Korrelasjon

Lang: -0.12 (neutral)

Kort: 0.24 (neutral)

Signal:(45.029) Neutral

Metropolis Healthcare Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Metropolis Healthcare Korrelasjon - Valuta/Råvare

0.51
( weak )

0.60
( weak )

0.38
( neutral )

0.44
( neutral )

0.16
( neutral )

Metropolis Healthcare Økonomi

Annual	2022
Omsetning:	INR11.48B
Bruttogevinst:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
Omsetning:	INR11.48B
Bruttogevinst:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
Omsetning:	INR12.28B
Bruttogevinst:	INR9.41B (76.59 %)
EPS:	INR41.87

FY	2021
Omsetning:	INR9.98B
Bruttogevinst:	INR7.38B (73.92 %)
EPS:	INR35.97

Financial Reports:

No articles found.

Metropolis Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Metropolis Healthcare Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.22%) | Divividend Growth Potential Score: 3.79 - Decrease likely (24.29%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR8.00	2020-02-13
Last Dividend	INR8.00	2023-02-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR32.00	--
Avg. Dividend % Per Year	0.30%	--
Score	1.82	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	3.79
Div. Directional Score	3.88	--

Next Divdend (Est)
(2024-12-31)

INR0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR8.00	0.56%
2021	INR8.00	0.40%
2022	INR8.00	0.23%
2023	INR8.00	0.61%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%
HBSL.NS	Dividend Junior	2023-08-11	Sporadic	12	0.78%
BEPL.NS	Dividend King	2023-07-25	Semi-Annually	20	4.91%
RADICO.NS	Dividend Junior	2023-09-14	Annually	22	0.24%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Junior	2023-08-04	Annually	23	0.57%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.108	1.500	7.85	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.75	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.18	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.791	1.000	0.155	0.155	[0.2 - 0.8]
operatingProfitMarginTTM	0.163	1.000	8.74	8.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	73.89	1.000	2.64	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.222	1.500	4.44	0	[0 - 0.4]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.22	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.55	0	[0.1 - 0.5]
Total Score				3.79

Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.